ChiCTR2100050616

Untitled Trial

Evaluation of the effects of thyroid function in patients with Hashimoto's thyroiditis after COVID 19 vaccination and study of vaccine safety and efficacy
The second Affiliated Hospital of Chongqing Medical University·Early Phase 1·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry
Study focus
Disease/Condition
Hashimoto Thyroiditis
Sponsor & location
Primary sponsor
The second Affiliated Hospital of Chongqing Medical University
Funder
National Natural Science Foundation of China (Grant No. 81370467)
Location
China
Timeline & enrollment
Phase
Early Phase 1
Start date
N/A
End date
Dec 31, 2022
ICD-10 classifications
ThyroiditisThyroiditis, unspecifiedDisorders of thyroid glandDisorder of thyroid, unspecifiedOther disorders of thyroid
Data source
Registry
Chinese Clinical Trial Registry
Trial ID
ChiCTR2100050616
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for ChiCTR2100050616 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by The second Affiliated Hospital of Chongqing Medical University and is currently Recruiting. The study focuses on Hashimoto Thyroiditis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.